Trius Acquired Last Week, Tetraphase Could Be Next
5d 1m 3m 1y 5y 10y
There are 2 articles on this stock available only to PRO subscribers.
There are no Transcripts on TTPH.
Business Wire (Thu, 7:00AM)
Business Wire (Tue, 9:03AM)
Business Wire (Feb 5, 2014)
Business Wire (Feb 4, 2014)
TTPH vs. ETF Alternatives
Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections.